Cite

HARVARD Citation

    Lee, R. et al. (2023). Efficacy and Safety of an Investigational Single-Course CRISPR Base-Editing Therapy Targeting PCSK9 in Nonhuman Primate and Mouse Models. Circulation. 147 (3), pp. 242-253. [Online]. 
  
Back to record